Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global topical antibiotics market size was valued at USD 6.27 billion in 2023, driven by the rising incidence of infectious diseases across the globe. The market is expected to grow at a CAGR of 3.8% during the forecast period of 2024-2032, with the values likely to rise from USD 6.51 billion in 2024 to USD 8.75 billion by 2032.
Topical antibiotics are used to treat skin infections via direct application on the affected site. They are widely available as creams, gels, and ointments. Topical antibiotics are agents that kill or inhibit the growth of their responsive micro-organisms. They are widely used in several conditions, from infections in cuts and in mild to severe acne cases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing incidence of diseases associated with pathogenic microorganisms has led to significant topical antibiotics market demand in recent years. Moreover, patients that have inadequate hygiene, a weak immune system, and an infected epidermis and close contact with people with epidermal disease are more vulnerable to illness. To combat the rising burden of infectious diseases, the market has flourished with several technical advancements to expediate the drug development process.
With the rising prevalence of multidrug resistance and development of superbugs, the decreased efficacy of antibiotics has been a key area of concern for scientists and researchers. Consequently, new chemical entities have emerged in the market to target the increasing antibiotic resistance issue. A prime example is quinolones, that target bacterial DNA gyrase and topoisomerase IV to achieve the antibacterial effects.
In July 2023, the FDA approved Verrica Pharmaceuticals’ therapy, VP-102 to treat molluscum contagiosum (molluscum) which is a highly contagious viral skin disease, affecting children under 16 years of age. This medication uses a drug-device combination with a controlled formulation of cantharidin (0.7% w/v) and is designed to be administered through a single-use applicator for topical dosing, facilitating targeted delivery. Such developments solidify the ongoing trend of blending non-pharmacological and pharmacological approaches to enable effective results for patients, indicating that the topical antibiotics market value is expected to grow further in the following years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The topical antibiotics market share has been dominated by the North America, specifically United States in the historical period. Extensive research on the assessment of the effectiveness and protection of the generic components used in antibiotics has become a key component of the growth of the regional industry. In addition, the robust research and development infrastructure also contributes to the market value in the region.
Apart from United States, Europe is another significant player in the market. The presence can be accredited to the existence of major research and academic institutions in the region. In addition, the prominent healthcare players also play a critical role in fostering innovation for developing new drugs.
It is estimated that the Asia Pacific region will witness fastest topical antibiotics market growth in the forecast period. The growth can be attributed to the increasing awareness about hygiene and sanitation spread by government as well as private institutions in the region. There is an influx of foreign capital in the region, with major healthcare and pharmaceutical companies setting up research laboratories to use the academic talent and other resources available in the area.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Application |
|
Breakup by Distribution Channel |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 6.27 billion in 2023, driven by the increasing prevalence of infectious diseases across the globe.
The market is anticipated to grow at a CAGR of 3.8% during the forecast period of 2024-2032, likely to reach a market value of USD 8.75 billion by 2032.
The market demand is driven by the rising population, growing awareness of treatment options, and increasing rising technological advancements for the development of novel therapeutics.
The current market trend revolves around increased number of drug approvals and the convergence of pharmacological and non-pharmacological techniques for rapid drug development. The FDA approval of Verrica to treat molluscum in children aged above 2 years of age is one such example.
Commonly used products include creams, ointments, gels, lotions, powders, and solutions, among others.
Common applications of the product include skin infections, eye infections, ear infections, and nasal infections, among others.
Major distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
Major end users include hospitals, clinics, ambulatory surgical centres, and homecare settings.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are F. Hoffmann-La Roche Ltd., Mylan N.V., Sanofi, Pfizer Inc., GlaxoSmithKline plc (GSK), Novartis AG, Bayer AG, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Lupin, Fresenius Kabi AG, Akorn Incorporated, Teva Pharmaceutical Industries Ltd., AstraZeneca plc., and Aurobindo Pharma.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share